← Back to Search

Lifestyle Intervention for High Blood Pressure (EPIPHANY Trial)

N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not taking any antihypertensive medication
No history of cardiovascular disease, diabetes, or chronic kidney disease
Must not have
Self-reported history of hypertension outside of pregnancy
Currently taking antihypertensive medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months,12 months, 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing an intervention to lower blood pressure in rural Black adults in Alabama, who have some of the highest rates in the US. The intervention includes group health education, online cooking and exercise classes, and support from health coaches.

Who is the study for?
This trial is for Black/African American adults living in rural Alabama with slightly elevated blood pressure, but not high enough to require medication. Participants should be under 65 years old without a history of heart disease, diabetes, or kidney issues and must speak English. They can't join if they're pregnant, planning to move soon, or don't have a phone.
What is being tested?
The study tests whether health education and peer support interventions delivered through churches can lower blood pressure among rural Black adults. Half the churches offer group education and online resources; the other half adds personalized telephone coaching from trained church members.
What are the potential side effects?
Since this trial focuses on lifestyle changes like diet improvements and increased physical activity rather than medications, side effects are minimal but may include muscle soreness from exercise or changes in digestion due to dietary adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not on any blood pressure medication.
Select...
I have no history of heart disease, diabetes, or kidney problems.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had high blood pressure not related to pregnancy.
Select...
I am currently on medication for high blood pressure.
Select...
I have a history of heart disease.
Select...
I cannot speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months,12 months, 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months,12 months, 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incident Blood Pressure
Secondary study objectives
Alcohol use
Fruit/Vegetable/Fiber Intake
Physical Activity
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Health Education & Peer CoachingExperimental Treatment3 Interventions
Participants will have access to online health education materials and will also be matched with a community health worker who will offer support through peer coaching
Group II: Health Education OnlyActive Control2 Interventions
Participants will have access to online health education materials but will not receive individualized peer support
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4410

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,341,856 Total Patients Enrolled

Media Library

Community-Level Peer Support Clinical Trial Eligibility Overview. Trial Name: NCT05367544 — N/A
High Blood Pressure Research Study Groups: Health Education & Peer Coaching, Health Education Only
High Blood Pressure Clinical Trial 2023: Community-Level Peer Support Highlights & Side Effects. Trial Name: NCT05367544 — N/A
Community-Level Peer Support 2023 Treatment Timeline for Medical Study. Trial Name: NCT05367544 — N/A
~109 spots leftby Jul 2025